B
NVO

Bailard’s Novo Nordisk NVO Stock Holding History

Bailard’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$255K Buy
+6,945
New +$329K 0.01% 655
2025
Q4 		– Sell
-14,737
Closed -$818K – 844
2025
Q3 		$818K Buy
14,737
+828
+6% +$48.5K 0.02% 367
2025
Q2 		$960K Buy
13,909
+941
+7% +$64K 0.02% 333
2025
Q1 		$900K Buy
12,968
+4,282
+49% +$354K 0.02% 327
2024
Q4 		$747K Sell
8,686
-3,662
-30% -$396K 0.02% 356
2024
Q3 		$1.47M Buy
12,348
+845
+7% +$113K 0.04% 258
2024
Q2 		$1.64M Sell
11,503
-892
-7% -$118K 0.05% 246
2024
Q1 		$1.59M Buy
12,395
+4,567
+58% +$544K 0.04% 249
2023
Q4 		$810K Sell
7,828
-363
-4% -$35.9K 0.02% 324
2023
Q3 		$745K Buy
8,191
+187
+2% +$16.5K 0.02% 321
2023
Q2 		$648K Buy
8,004
+842
+12% +$68.8K 0.02% 335
2023
Q1 		$570K Buy
7,162
+60
+0.8% +$4.25K 0.02% 366
2022
Q4 		$481K Sell
7,102
-834
-11% -$48.9K 0.02% 409
2022
Q3 		$395K Buy
7,936
+322
+4% +$17.3K 0.02% 409
2022
Q2 		$424K Sell
7,614
-824
-10% -$45.7K 0.02% 405
2022
Q1 		$469K Buy
8,438
+1,496
+22% +$76.8K 0.02% 418
2021
Q4 		$389K Buy
+6,942
New +$376K 0.01% 455

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Bailard's NVO Position: Q1 2026 in Review

Bailard opened a new position in Novo Nordisk (NVO) in Q1 2026: 6,945 shares worth $255K. The stake represents 0.01% of the portfolio and ranks #655 among its holdings. This is a return to the name: Bailard previously reported a position in NVO as recently as Q3 2025.

Bailard first reported a position in NVO in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.64M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Bailard held 6,945 shares of Novo Nordisk worth $255K as of Q1 2026.
  • Novo Nordisk was a new Bailard position in Q1 2026.
  • Novo Nordisk made up 0.01% of Bailard's portfolio in Q1 2026, its #655 holding.
  • Bailard first reported a position in Novo Nordisk in Q4 2021 and has held it in 17 quarters since.
  • Bailard's Novo Nordisk position peaked at $1.64M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.